JP2024543138A - Ｒｎａバイオマーカーの検出方法 - Google Patents

Ｒｎａバイオマーカーの検出方法 Download PDF

Info

Publication number
JP2024543138A
JP2024543138A JP2024531107A JP2024531107A JP2024543138A JP 2024543138 A JP2024543138 A JP 2024543138A JP 2024531107 A JP2024531107 A JP 2024531107A JP 2024531107 A JP2024531107 A JP 2024531107A JP 2024543138 A JP2024543138 A JP 2024543138A
Authority
JP
Japan
Prior art keywords
cancer
tumor
expression
rna
itf3756
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024531107A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543138A5 (enExample
Inventor
フォサーティ ジャンルカ
リパモンティ キアラ
ステインクーラー クリスティアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Publication of JP2024543138A publication Critical patent/JP2024543138A/ja
Publication of JP2024543138A5 publication Critical patent/JP2024543138A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2561/00—Nucleic acid detection characterised by assay method
    • C12Q2561/101—Taqman
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2024531107A 2021-11-23 2022-11-22 Ｒｎａバイオマーカーの検出方法 Pending JP2024543138A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT202100029558 2021-11-23
IT102021000029558 2021-11-23
PCT/EP2022/082762 WO2023094365A1 (en) 2021-11-23 2022-11-22 Method to detect rna biomarkers

Publications (2)

Publication Number Publication Date
JP2024543138A true JP2024543138A (ja) 2024-11-19
JP2024543138A5 JP2024543138A5 (enExample) 2025-10-08

Family

ID=80121649

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024531107A Pending JP2024543138A (ja) 2021-11-23 2022-11-22 Ｒｎａバイオマーカーの検出方法

Country Status (9)

Country Link
US (1) US20250011878A1 (enExample)
EP (1) EP4437138A1 (enExample)
JP (1) JP2024543138A (enExample)
KR (1) KR20240105468A (enExample)
CN (1) CN118202068A (enExample)
AR (1) AR127708A1 (enExample)
CA (1) CA3235259A1 (enExample)
TW (1) TW202340480A (enExample)
WO (1) WO2023094365A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025080842A1 (en) * 2023-10-11 2025-04-17 Dana-Farber Cancer Institute, Inc. Methods of cancer detection, prediction of response to therapy, and treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012018499A2 (en) * 2010-08-05 2012-02-09 Acetylon Pharmaceuticals Specific regulation of cytokine levels by hdac6 inhibitors
US20120176076A1 (en) 2011-01-10 2012-07-12 Carl Mansfield Methods and systems for powering auxiliary devices in photovol taic system
WO2014032899A1 (en) * 2012-08-31 2014-03-06 Novo Nordisk A/S Diagnosis and treatment of lupus nephritis
EP3084446B1 (en) * 2013-12-20 2022-12-14 Acetylon Pharmaceuticals, Inc. Histone deacetylase 6 (hdac6) biomarkers in multiple myeloma
CA2995520A1 (en) * 2015-08-14 2017-02-23 Hendrik Jan VAN OOIJEN Assessment of nfkb cellular signaling pathway activity using mathematical modelling of target gene expression
WO2017070441A1 (en) * 2015-10-23 2017-04-27 Icahn School Of Medicine At Mount Sinai Identifying and treating cancer patients who are suitable for a targeted therapy using an hdac6 inhibitor
IT201700041723A1 (it) 2017-04-14 2018-10-14 Italfarmaco Spa Nuovi inibitori selettivi di HDAC6

Also Published As

Publication number Publication date
CA3235259A1 (en) 2023-06-01
US20250011878A1 (en) 2025-01-09
WO2023094365A1 (en) 2023-06-01
TW202340480A (zh) 2023-10-16
CN118202068A (zh) 2024-06-14
KR20240105468A (ko) 2024-07-05
EP4437138A1 (en) 2024-10-02
AR127708A1 (es) 2024-02-21

Similar Documents

Publication Publication Date Title
US12247982B2 (en) Markers selectively deregulated in tumor-infiltrating regulatory T cells
El-Mogy et al. Diversity and signature of small RNA in different bodily fluids using next generation sequencing
Cheng et al. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood
Huang et al. Up-regulation of circRNA-0003528 promotes mycobacterium tuberculosis associated macrophage polarization via down-regulating miR-224-5p, miR-324-5p and miR-488-5p and up-regulating CTLA4
US20140018409A1 (en) Method for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells
KR102487727B1 (ko) 암 예후 예측을 위한 조성물 및 이를 포함하는 키트
Chini et al. Novel long non-coding RNAs associated with inflammation and macrophage activation in human
Senousy et al. LncRNA GAS5 and miR-137 polymorphisms and expression are associated with multiple sclerosis risk: mechanistic insights and potential clinical impact
BR112016002716A2 (pt) coortes de biomarcador de urina, assinaturas de expressão gênica e métodos de uso das mesmas
Houtman et al. T cells are influenced by a long non-coding RNA in the autoimmune associated PTPN2 locus
CN103003442A (zh) 一种通过微小rna表达水平评估人同种异体移植物状况的方法
Verma et al. Leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction induces a novel genetic signature resulting in T-cells refractory to transforming growth factor-β signaling
Chen et al. Lnc-M2 controls M2 macrophage differentiation via the PKA/CREB pathway
WO2015121417A1 (de) Prädiktive mrna biomarker zur vorhersage der behandlung mit methotrexat (mtx)
Bian et al. Gm15575 functions as a ceRNA to up-regulate CCL7 expression through sponging miR-686 in Th17 cells
CN117295952A (zh) 用于预测溃疡性结肠炎中治疗响应的方法
JP2024543138A (ja) Ｒｎａバイオマーカーの検出方法
Yu et al. Genes regulated by Nkx2-3 in siRNA-mediated knockdown B cells: implication of endothelin-1 in inflammatory bowel disease
Bennett et al. Micro RNA’s (mirna’s) may help explain expression of multiple genes in Alzheimer’s frontal cortex
Chen et al. SPATS2L is a positive feedback regulator of the type I interferon signaling pathway and plays a vital role in lupus: SPATS2L in SLE: a crucial IFN signaling regulator
EP4455308A1 (en) Il-7r gene signatures
EP3255433A1 (en) Methods using blm as a marker of multiple myeloma
US20240263237A1 (en) T cell transcriptomic profiles in parkinson's disease, and methods and uses thereof
Wu et al. Epigenetically silencing gluconeogenic enzyme PCK1 by EZH2 promotes renal tubulointerstitial fibrosis
Mashreghi et al. THU0467 Silencing of the MEFV Gene in Familial Mediterranean Fever and Transcriptomic Analysis in Human Monocytes: Evidence for the Involvement of Pyrin in Innate Immune Responses and Autophagy

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240716

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250926

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250926